ARCHIVES

Talactoferrin Second-Line Therapy Increases Survival In Stage IIIB/IV

This article is from The Cancer Letter archive.

Vol. 34 No. 10 | October 28, 2011

Download PDF Visit The Full Archive

Related Articles

NCI Announces Designation Of Comprehensive Center

July 20, 1990

False-Positive Mammograms Can Indicate Higher Cancer Risk

April 27, 2012

ASCO Lists Top 11 Advances In Clinical Cancer Research

December 30, 2005

Poll Finds Voters Support Doubling Of Research Funds.

November 3, 2000

HER2+ Tumors Increase Risk Of Recurrence, Study Finds

November 27, 2009

NCI Advisory Group, Other Cancer Meetings

February 24, 1984